Actavia Life Sciences, Inc.
RASP
Rank in Stocks
#33521
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing... Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
Share Price
$0.0005
Last synced: 2026-11-13
Market Cap
$385.91K
Change (1 day)
0.00%
Change (1 year)
-87.50%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Actavia Life Sciences, Inc. (RASP)
Category
Healthcare
EPS for Actavia Life Sciences, Inc. (RASP)
EPS as of March 2024 TTM: $0.00
According to Actavia Life Sciences, Inc.'s latest financial reports, its current EPS (TTM) is $0.00. At the end of 2023 the company had an EPS of $-0.01, equal to its 2022 EPS of $-0.01.
EPS history for Actavia Life Sciences, Inc. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | -95.00% |
| 2023 | $-0.01 | -23.00% |
| 2022 | $-0.01 | -21.26% |
| 2021 | $-0.01 | -83.63% |
| 2020 | $-0.08 | 470.59% |
| 2019 | $-0.01 | -77.10% |
| 2018 | $-0.06 | 924.14% |
| 2016 | $-0.01 | 262.50% |
| 2015 | 0.00 | -56.76% |
| 2014 | 0.00 | 236.36% |
| 2013 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 177,900.00% |
US
|
|
| $15.66 | -3,132,100.00% |
US
|
|
| $-7.07 | 1,413,900.00% |
US
|
|
| $-5.29 | 1,057,900.00% |
AU
|
|
| $12.73 | -2,546,540.00% |
BE
|
Questions about Actavia Life Sciences, Inc.'s earnings per share (EPS)
What is Actavia Life Sciences, Inc.'s earnings per share (EPS)?
Actavia Life Sciences, Inc.'s earnings per share (EPS) over the last twelve months is $0.00, as of Mar 2024.
What was Actavia Life Sciences, Inc.'s earnings per share (EPS) in 2023?
In 2023, Actavia Life Sciences, Inc.'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2022.
How has Actavia Life Sciences, Inc.'s earnings per share (EPS) changed since 2018?
From 2018 to 2023, Actavia Life Sciences, Inc.'s earnings per share (EPS) was highest in 2023 ($-0.01) and lowest in 2020 ($-0.08).
How does Actavia Life Sciences, Inc.'s earnings per share (EPS) compare with similar companies?
Actavia Life Sciences, Inc.'s earnings per share (EPS) ($0.00) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.